CIK: 2025233 - Address: Monte Rosa Therapeutics, Inc., 321 Harrison Avenue, Suite 900, Boston, MA 02118
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
6/25/26 16:05
6/23/26
GLUEMonte Rosa Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagChampoux JenniferMAOCOOM.d93.9802462D
6/25/26 16:05
6/23/26
GLUEMonte Rosa Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagChampoux JenniferMAOCOOS.d-4420.000-2-362D
6/18/26 16:05
6/17/26
GLUEMonte Rosa Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagChampoux JenniferMAOCOOM.d93.9802462D
6/18/26 16:05
6/17/26
GLUEMonte Rosa Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagChampoux JenniferMAOCOOS.d-4119.000-2-362D
5/28/26 19:10
5/27/26
GLUEMonte Rosa Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagChampoux JenniferMAOCOOM.d93.9802462D
5/28/26 19:10
5/27/26
GLUEMonte Rosa Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagChampoux JenniferMAOCOOS.d-4420.000-2-362D
5/26/26 16:05
5/22/26
GLUEMonte Rosa Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagChampoux JenniferMAOCOOM.d93.9802462D
5/26/26 16:05
5/22/26
GLUEMonte Rosa Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagChampoux JenniferMAOCOOS.d-4119.000-2-362D
1/5/26 16:05
1/5/26
GLUEMonte Rosa Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagChampoux JenniferMAOCOOS.d-4015.170-3-462D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact